Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades' - Cleveland-Cliffs (NYSE:CLF), Bristol-Myers Squibb (NYSE:BMY)
Benzinga·2025-11-03 13:12

Group 1: Cleveland-Cliffs Inc. - Goldman Sachs analyst Mike Harris maintained a Buy rating on Cleveland-Cliffs and raised the price target from $14.5 to $16 [1] Group 2: Rocket Companies, Inc. - Rocket Companies reported better-than-expected third-quarter earnings of 7 cents per share, beating the Street estimate of 5 cents [2] - Quarterly revenue for Rocket Companies was $1.78 billion, surpassing the consensus estimate of $1.66 billion [2] - Rocket shares gained 4.5% to close at $16.66 [6] Group 3: Meta Platforms, Inc. - Meta reported quarterly diluted earnings per share of $1.05, which includes a one-time, non-cash income tax charge of $15.93 billion [3] - On an adjusted basis, Meta's earnings per share came in at $7.25 [3] - Meta shares fell 2.7% to close at $648.35 [6] Group 4: Bristol-Myers Squibb Company - Bristol-Myers Squibb reported third-quarter revenues of $12.22 billion, beating the consensus of $11.81 billion, representing a 3% increase year over year [4] - Bristol-Myers Squibb shares gained 1% to close at $46.07 [6]